BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36480828)

  • 1. [Diagnostic values of cyclin D1 immunocytochemistry and molecular testing in preoperative fine needle aspiration of undeterminate thyroid nodules].
    He SR; Zhang JX; Chen RM; Hu ST; Yang L; Chen L; Zhang Z; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1210-1216. PubMed ID: 36480828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic values of nuclear score combined with cyclin D1 immunocytochemistry in indeterminate thyroid follicular nodules in preoperative fine needle aspiration].
    He SR; Liu LT; Chen RM; Wang MG; Hu ST; Miao G; Chen L; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):696-701. PubMed ID: 37408400
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
    BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.
    Tang J; Ma J; Xi X; Wang L; Li H; Huo S; Zhang B
    Endocrine; 2023 Jun; 80(3):552-562. PubMed ID: 36542267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF
    Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
    Sheng D; Yu X; Li H; Zhang M; Chen J
    Medicine (Baltimore); 2021 Sep; 100(37):e27167. PubMed ID: 34664843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
    Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
    J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P; Scappaticcio L; Treglia G; Guidobaldi L; Bongiovanni M; Giovanella L
    Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhu Y; Wu H; Huang B; Shen X; Cai G; Gu X
    Gland Surg; 2020 Oct; 9(5):1674-1684. PubMed ID: 33224845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
    Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
    Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
    [No Abstract]   [Full Text] [Related]  

  • 13. Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.
    Gokozan HN; Dilcher TL; Alperstein SA; Qiu Y; Mostyka M; Scognamiglio T; Solomon JP; Song W; Rennert H; Beg S; Stern E; Goyal A; Siddiqui MT; Heymann JJ
    Cancer Cytopathol; 2022 Apr; 130(4):259-274. PubMed ID: 34962713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAF
    Chirayath SR; Pavithran PV; Abraham N; Nair V; Bhavani N; Kumar H; Menon UV; Menon AS
    Indian J Endocrinol Metab; 2019; 23(3):278-281. PubMed ID: 31641627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
    Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
    [No Abstract]   [Full Text] [Related]  

  • 16. A five-gene panel refines differential diagnosis of thyroid nodules.
    Lu SY; Chen YC; Zhu CF; Chen J; Zhou QY; Zhang MM; Zhang QY; Lu M; Yang L; Wu J; Zhao SX; Song HD; Ye XP
    J Clin Lab Anal; 2021 Sep; 35(9):e23920. PubMed ID: 34318534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Testing for
    Gupta O; Gautam U; Chandrasekhar M; Rajwanshi A; Radotra BD; Verma R; Srinivasan R
    J Cytol; 2020; 37(4):174-181. PubMed ID: 33776257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
    Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
    [No Abstract]   [Full Text] [Related]  

  • 20. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of
    Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.